The Immune Response Corporation Announces Rebranding to Reflect ...
PharmaLive.com (press release) - Newtown,PA,USA
NeuroVax(TM), an investigational T-Cell Receptor peptide vaccine for the treatment of relapsing-remitting forms of MS, appears to work by enhancing levels ...
See all stories on this topic